e 5880 has been researched along with thromboxane b2 in 2 studies
| Studies (e 5880) | Trials (e 5880) | Recent Studies (post-2010) (e 5880) | Studies (thromboxane b2) | Trials (thromboxane b2) | Recent Studies (post-2010) (thromboxane b2) |
|---|---|---|---|---|---|
| 35 | 2 | 8 | 7,483 | 715 | 485 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, S; Hirashima, Y; Kato, R; Takaku, A | 1 |
| Ando, H; Kobayashi, K; Nakatani, T; Sakamoto, Y | 1 |
2 other study(ies) available for e 5880 and thromboxane b2
| Article | Year |
|---|---|
Prevention of cerebrovasospasm following subarachnoid hemorrhage in rabbits by the platelet-activating factor antagonist, E5880.
Topics: Animals; Female; Ischemic Attack, Transient; Piperidines; Pyridinium Compounds; Rabbits; Subarachnoid Hemorrhage; Thromboxane B2 | 1996 |
Effects of platelet-activating factor antagonist E5880 on intrahepatic and systemic metabolic responses to transient hepatic inflow occlusion and reperfusion in the rabbit.
Topics: 6-Ketoprostaglandin F1 alpha; Adenine Nucleotides; Ammonia; Analysis of Variance; Animals; Blood Gas Analysis; Blood Glucose; Energy Metabolism; Hydrogen-Ion Concentration; Lactic Acid; Liver; Male; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Pyruvic Acid; Rabbits; Reperfusion Injury; Thromboxane B2 | 1996 |